Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase (original) (raw)

References

Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y . 1998 Science 281: 1674–1677
Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A . 1996 Cell 86: 159–171
Barlow C, Eckhaus MA, Schaffer AA, Wynshaw-Boris A . 1999 Nature Gen. 21: 359–360
Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B . 1997 Biochim. Biophys. Acta 1332: F105–F126
Beamish H, Williams R, Chen P, Lavin MF . 1996 J. Biol. Chem. 271: 20486–20493
Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J . 1996 Proc. Natl. Acad. Sci. USA 93: 7263–7268
Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD . 1998 Science 281: 1677–1679
Chao C, Saito S, Anderson CW, Appella E, Xu Y . 2000 Proc. Natl. Acad. Sci. USA 97: 11936–11941
Chernicky CL, Yi L, Tan H, Gan SU, Ilan J . 2000 Cancer Gene Ther. 7: 384–395
Dunn SE, Hardman RA, Kari FW, Barrett JC . 1997 Cancer Res. 57: 2687–2693
Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P . 1996 Proc. Natl. Acad. Sci. USA 93: 13084–13089
Fan Z, Chakravarty P, Alfieri A, Pandita TK, Vikram B, Guha C . 2000 Cancer Gene Ther. 7: 1307–1314
Fukao T, Kaneko H, Birrell G, Gatei M, Tashita H, Yoshida T, Cross S, Kedar P, Watters D, Khanna KK, Misko I, Kondo N, Lavin MF . 1999 Blood 94: 1998–2006
Fukuchi K, Watanabe H, Tomoyasu S, Ichimura S, Tatsumi K, Gomi K . 2000 Biochim. Biophys. Acta 1496: 207–220
Gooch JL, Van Den Berg CL, Yee D . 1999 Breast Cancer Res. Treat. 56: 1–10
Gueven N, Keating KE, Chen P, Fukao T, Khanna KK, Watters D, Rodemann PH, Lavin MF . 2001 J. Biol. Chem. 276: 8884–8891
Guha C, Guha U, Tribius S, Alfieri A, Casper D, Chakravarty P, Mellado W, Pandita TK, Vikram B . 2000 Gene Ther. 7: 852–858
Hartmann A, Blaszyk H, Cunningham JS, McGovern RM, Schroeder JS, Helander SD, Pittelkow MR, Sommer SS, Kovach JS . 1996 Int. J. Cancer 67: 313–317
Hartmann KK, Baier TG, Papa V, Kronenwett M, Brown EJ, Goldfine ID, Rosenthal SM . 1992 J. Cell. Biochem. 48: 81–85
Huang S-M, Bock JM, Harari PM . 1999 Cancer Res. 59: 1935–1940
Jenrette JM . 1996 Semin. Oncol. 23: 759–762
Jones RF, Matuszk J, Debiec-Rychter M, Wang CY . 1994 Mol. Carcinog. 9: 95–104
Kanter-Lewensohn L, Dricu A, Girnita L, Wejde J, Larsson O . 2000 Growth Factors 17: 193–202
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ . 1992 Cell 71: 587–597
Kastan MB, Lim D-S . 2000 Nature Rev. Mol. Cell. Biol. 1: 179–186
Kelland LR, Steele GG . 1989 Int. J. Radiat. Biol. 55: 119–127
Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE . 2000 Endocr. Rev. 21: 215–244
Khanna KK, Lavin MF . 1993 Oncogene 8: 3307–3312
Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP, Lavin MF . 1998 Nature Genet. 20: 398–400
Khanna KK . 2000 J. Natl. Cancer Inst. 92: 795–802
Kizilian N, Wilkins RC, Reinhardt P, Ferrarotto C, McLean JRN, McNamee JP . 1999 Biotechniques 27: 926–930
Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Waldmann TA, Nissley SP . 1987 Cell. Immunol. 109: 318–331
Kwok TT, Sutherland RM . 1989 J. Natl. Cancer Inst. 81: 1020–1024
Lavin MF . 2000 Nature Cell. Biol. 2: E1–E3
Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP . 1996 Cancer Res. 56: 3038–3041
LeRoith D, Bondy C, Yakar S, Liu J-L, Butler A . 2000 Endocr. Rev. 22: 53–74
Lim D-S, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB . 2000 Nature 404: 613–617
Liu X, Turbyville T, Fritz A, Whitesell L . 1998 Cancer Res. 58: 5432–5438
Lu X, Lane DP . 1993 Cell 75: 765–778
Macaulay VM . 1992 Br. J. Cancer 65: 311–320
Morgan SE, Kastan MB . 1997 Adv. Cancer Res. 71: 1–25
Nakamura S, Watanabe H, Miura M, Sasaki T . 1997 Exp. Cell. Res. 235: 287–294
Olive PL, Wlodek D, Banath JP . 1991 Cancer Res. 51: 4671–4676
Pandita TK, Lieberman HB, Lim DS, Dhar S, Zheng W, Taya Y, Kastan MB . 2000 Oncogene 19: 1386–1391
Peretz S, Jensen R, Baserga R, Glazer PM . 2001 Proc. Natl. Acad. Sci. USA 98: 1676–1681
Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R . 1999 Mol. Cell. Biol. 19: 7203–7215
Pietras RJ, Poen JC, Gallardo D, Wongvipat N, Lee HJ, Slamon DJ . 1999 Cancer Res. 59: 1347–1355
Playford MP, Bicknell D, Bodmer WF, Macaulay VM . 2000 Proc. Natl. Acad. Sci. USA 97: 12103–12108
Ramsay J, Birrell G, Baumann K, Bodero A, Parsons P, Lavin M . 1998 Br. J. Cancer 77: 11–14
Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R . 1994a Cancer Res. 54: 2218–2222
Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R . 1994b Cancer Res. 54: 4848–4850
Rofstad EK . 1992 Int. J. Radiat. Oncol. Biol. Phys. 23: 63–68
Rotman G, Shiloh Y . 1999 Oncogene 18: 6135–6144
Savitsky K, Platzer M, Uziel T, Gilad S, Sartiel A, Rosenthal A, Elroy-Stein O, Shiloh Y, Rotman G . 1997 Nucl. Acids Res. 25: 1678–1684
Shiloh Y . 1995 Eur. J. Hum. Genet. 3: 116–138
Shiloh Y . 2001a ATM: Sounding the double-strand break alarm. Cold Spring Harbor Symposia on Quantitative Biology, Biological Responses to DNA Damage 65: in press
Shiloh Y . 2001b Curr. Opin. Genet. Dev. 11: 71–77
Smith K, Bui TD, Poulsom R, Kaklamanis L, Williams G, Harris AL . 1999 Br. J. Cancer 81: 496–502
Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E . 1989 J. Biol. Chem. 264: 21544–21549
Tsuboi K, Tsuchida Y, Endo K, Yoshii Y, Nose T . 1997 Brain Tumour Path. 14: 19–25
Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM . 1997 Cancer Res. 57: 3079–3083
Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et al. 1986 EMBO J. 5: 2503–2512
Vojtesek B, Dolezalova H, Lauerova L, Svitakova M, Havlis P, Kovarik J, Midgeley CA, Lane DP . 1995 Oncogene 10: 389–393
Wang YA, Elson A, Leder P . 1997 Proc. Natl. Acad. Sci. USA 94: 14590–14595
Wang H, Liu Y, Wei L, Guo Y . 2000 Antisense IGF and antisense IGF-IR therapy of malignancy. In Cancer Gene Therapy: Past Achievements and Future Challenges Habib (ed) Klewer/Plenum: New York pp. 265–272
Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P . 1997 Cancer Res. 57: 1664–1667
Whitesell L, Liu X, Bagatell R . 1999 Methods: A Companion to Methods in Enzymology 18: 296–303
Wollman R, Yahalom J, Maxy R, Pinto J, Fuks Z . 1994 Int. J. Radiat. Oncol. Biol. Phys. 30: 91–98
Wouters BG, Denko NC, Giaccia AJ, Brown JM . 1999 Oncogene 18: 6540–6545
Wu X, Ranganathan V, Weisman DS, Heine WF, Ciccone DN, O'Neill TB, Crick KE, Pierce KA, Lane WS, Rathburn G, Livingston DM, Weaver DT . 2000 Nature 405: 477–482
Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA . 1998 Oncogene 16: 721–736
Xu Y, Baltimore D . 1996 Genes Dev. 10: 2401–2410
Yang D-Q, Kastan MB . 2000 Nature Cell. Biol. 2: 893–898
Zhang L, Kim M, Choi YH, Goemans B, Yeung C, Hu Z, Zhan S, Seth P, Helman LJ . 1999 J. Biol. Chem. 274: 13118–13126
Zhang N, Chen P, Gatei M, Scott S, Khanna KK, Lavin MF . 1998 Oncogene 17: 811–818
Zhao S, Weng Y-C, Yuan S-SF, Lin Y-T, Hsu H-C, Lin S-CJ, Berbino E, Song M, Zdzienicka MZ, Gatti RA, Shay JW, Ziv Y, Shiloh Y, Lee EY-HP . 2000 Nature 405: 473–477

Download references